Beverly, MA, United States of America

John Rush

USPTO Granted Patents = 5 


Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of John Rush in Biotechnology

Introduction

John Rush, a prominent inventor hailing from Beverly, MA, has made significant strides in the field of biotechnology. With an impressive portfolio of five patents, Rush has focused his research on immunoaffinity isolation methods and the identification of novel phosphorylation sites, contributing to advances in diagnostic and therapeutic applications.

Latest Patents

One of Rush's notable inventions is the method for the immunoaffinity isolation of modified peptides from complex mixtures. This innovative approach includes several steps: obtaining a proteinaceous preparation from an organism containing modified peptides, contacting this preparation with immobilized modification-specific antibodies, and isolating the modified peptides that specifically bind to these antibodies. Furthermore, this invention also encompasses characterizing the isolated modified peptide by techniques such as mass spectrometry and utilizing software to match spectra with known peptide sequences. Additionally, Rush has contributed to the development of an immunoaffinity isolation device featuring modification-specific antibodies and novel antibodies against UFD1 and PTN6 phosphorylation sites.

Another significant contribution is the discovery of 155 novel phosphorylation sites identified in carcinoma and leukemia, along with the development of peptides and antibodies that specifically bind to these phosphorylation sites. This work has potential diagnostic and therapeutic implications, which underscores Rush's impact on cancer research and treatment.

Career Highlights

John Rush currently works at Cell Signaling Technology, Inc., a company renowned for its cutting-edge research and development in the field of cell signaling and cancer diagnostics. His role at this esteemed organization allows him to collaborate with talented professionals and push the boundaries of biotechnology.

Collaborations

Rush has worked closely with notable coworkers Albrecht Moritz and Kimberly A. Lee, leveraging their combined expertise to explore innovative solutions in the realm of peptide modification and phosphorylation. This collaboration highlights the synergy of interdisciplinary efforts in advancing scientific understanding and creating impactful technologies.

Conclusion

John Rush’s innovations have paved the way for significant developments in biotechnology, particularly in cancer diagnostics and treatment. His commitment to research and collaboration with other experts exemplifies the spirit of innovation that drives the scientific community forward. Through his patents and ongoing work, Rush continues to contribute to the understanding of complex biological processes, making him a key figure in modern biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…